Glycyx Mor, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Francisco, CA
SAM.gov UEIC2B7XPCFTHC7
Glycyx is a biotechnology company developing a lead drug candidate for immuno-oncology that restores immune function and enables T-cell infiltration into tumors when combined with immune checkpoint inhibitors. The drug is designed to reverse the immunosuppressive effects of opioids without compromising pain relief and to amplify the effectiveness of anti-PD1/PD-L1 cancer treatments. The company is preparing for Phase 2 clinical trials and serves cancer patients.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Glycyx Mor, INC. | San Francisco | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.